Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
1.
COPD ; 19(1): 265-273, 2022 05 20.
Article in English | MEDLINE | ID: mdl-35639442

ABSTRACT

Limited information is available regarding the role of anaerobic metabolism capacity on GOLD 1 and 2 COPD patients during upper limb exercise. We aimed to compare the upper limb anaerobic power capacity, blood lactate concentration, cardiovascular and respiratory responses, in male COPD patients versus healthy subjects during the 30-s Wingate anaerobic test (WAnT). The rate of fatigue and time constant of the power output decay (τ, tau) were also calculated and a regression analysis model was built to assess the predictors of τ in these patients. Twenty-four male COPD patients (post-bronchodilator FEV1 73.2 ± 15.3% of predicted) and 17 healthy subjects (FEV1 103.5 ± 10.1% of predicted) underwent the WAnT. Measurements were performed at rest, at the end of the WAnT, and during 3' and 5' of recovery time. Peak power (p = 0.04), low power (p = 0.002), and mean power output (p = 0.008) were significantly lower in COPD patients than in healthy subjects. Power output decreased exponentially in both groups, but at a significantly faster rate (p = 0.007) in COPD patients. The time constant of power decay was associated with resistance (in ohms) and fat-free mass (r2 = 0.604, adjusted r2 = 0.555, and p = 0.002). Blood lactate concentration was significantly higher in healthy subjects at the end of the test, as well as during 3' and 5' of recovery time (p < 0.01). Compared with healthy subjects, COPD patients with GOLD 1 and 2 presented lower upper limb anaerobic capacity and a faster rate of power output decrease during a maximal intensity exercise. Also, the WAnT proved to be a valid tool to measure the upper limb anaerobic capacity in these patients.


Subject(s)
Exercise Test , Pulmonary Disease, Chronic Obstructive , Anaerobiosis , Humans , Lactic Acid , Male , Upper Extremity
2.
ERJ Open Res ; 7(1)2021 Jan.
Article in English | MEDLINE | ID: mdl-33569499

ABSTRACT

BACKGROUND: Patients with unilateral diaphragmatic paralysis (UDP) may present with dyspnoea without specific cause and limited ability to exercise. We aimed to investigate the diaphragm contraction mechanisms and nondiaphragmatic inspiratory muscle activation during exercise in patients with UDP, compared with healthy individuals. METHODS: Pulmonary function, as well as volitional and nonvolitional inspiratory muscle strength were evaluated in 35 patients and in 20 healthy subjects. Respiratory pressures and electromyography of scalene and sternocleidomastoid muscles were continuously recorded during incremental maximal cardiopulmonary exercise testing until symptom limitation. Dyspnoea was assessed at rest, every 2 min during exercise and at the end of exercise with a modified Borg scale. MAIN RESULTS: Inspiratory muscle strength measurements were significantly lower for patients in comparison to controls (all p<0.05). Patients achieved lower peak of exercise (lower oxygen consumption) compared to controls, with both gastric (-9.8±4.6 cmH2O versus 8.9±6.0 cmH2O) and transdiaphragmatic (6.5±5.5 cmH2O versus 26.9±10.9 cmH2O) pressures significantly lower, along with larger activation of both scalene (40±22% EMGmax versus 18±14% EMGmax) and sternocleidomastoid (34±22% EMGmax versus 14±8% EMGmax). In addition, the paralysis group presented significant differences in breathing pattern during exercise (lower tidal volume and higher respiratory rate) with more dyspnoea symptoms compared to the control group. CONCLUSION: The paralysis group presented with exercise limitation accompanied by impairment in transdiaphragmatic pressure generation and larger accessory inspiratory muscles activation compared to controls, thereby contributing to a neuromechanical dissociation and increased dyspnoea perception.

3.
BMC Pulm Med ; 18(1): 126, 2018 Aug 02.
Article in English | MEDLINE | ID: mdl-30068327

ABSTRACT

BACKGROUND: Most patients with unilateral diaphragm paralysis (UDP) have unexplained dyspnea, exercise limitations, and reduction in inspiratory muscle capacity. We aimed to evaluate the generation of pressure in each hemidiaphragm separately and its contribution to overall inspiratory strength. METHODS: Twenty-seven patients, 9 in right paralysis group (RP) and 18 in left paralysis group (LP), with forced vital capacity (FVC) < 80% pred, and 20 healthy controls (CG), with forced expiratory volume in 1 s (FEV1) > 80% pred and FVC > 80% pred, were evaluated for lung function, maximal inspiratory (MIP) and expiratory (MEP) pressure measurements, diaphragm ultrasound, and transdiaphragmatic pressure during magnetic phrenic nerve stimulation (PdiTw). RESULTS: RP and LP had significant inspiratory muscle weakness compared to controls, detected by MIP (- 57.4 ± 16.9 for RP; - 67.1 ± 28.5 for LP and - 103.1 ± 30.4 cmH2O for CG) and also by PdiTW (5.7 ± 4 for RP; 4.8 ± 2.3 for LP and 15.3 ± 5.7 cmH2O for CG). The PdiTw was reduced even when the non-paralyzed hemidiaphragm was stimulated, mainly due to the low contribution of gastric pressure (around 30%), regardless of whether the paralysis was in the right or left hemidiaphragm. On the other hand, in CG, esophagic and gastric pressures had similar contribution to the overall Pdi (around 50%). Comparing both paralyzed and non-paralyzed hemidiaphragms, the mobility during quiet and deep breathing, and thickness at functional residual capacity (FRC) and total lung capacity (TLC), were significantly reduced in paralyzed hemidiaphragm. In addition, thickness fraction was extremely diminished when contrasted with the non-paralyzed hemidiaphragm. CONCLUSIONS: In symptomatic patients with UDP, global inspiratory strength is reduced not only due to weakness in the paralyzed hemidiaphragm but also to impairment in the pressure generated by the non-paralyzed hemidiaphragm.


Subject(s)
Diaphragm/diagnostic imaging , Diaphragm/physiopathology , Pressure , Respiratory Paralysis/physiopathology , Adult , Aged , Case-Control Studies , Cross-Sectional Studies , Female , Forced Expiratory Volume , Functional Residual Capacity , Humans , Male , Middle Aged , Phrenic Nerve/physiopathology , Respiratory Paralysis/pathology , Ultrasonography , Vital Capacity
4.
J Cardiopulm Rehabil Prev ; 36(6): 402-412, 2016.
Article in English | MEDLINE | ID: mdl-27780184

ABSTRACT

PURPOSE: The mechanisms underlying physiological limitations during arm activity in individuals with chronic obstructive pulmonary disease (COPD) are unknown. The objective of this systematic review was to describe cardiorespiratory responses, symptoms, chest wall kinematics, muscle activity, and lung volumes during arm activity in individuals with COPD relative to the responses of healthy controls. METHODS: Original research articles that compared cardiorespiratory responses, symptoms, muscle activity, chest wall kinematics, and lung function during arm activity between individuals with COPD and healthy controls were identified after searches of 5 electronic databases and reference lists of pertinent articles. Two reviewers performed the electronic and manual searches with 1 screening title and abstracts. Two investigators screened the full texts to determine eligibility for inclusion. One reviewer performed the data extraction and tabulation using a standardized form with a second reviewer double-checking the data extracted. RESULTS: Of the 54 full-text articles assessed for eligibility, 6 met the inclusion criteria. Reduced cardiorespiratory responses during peak arm exercise in individuals with COPD compared with healthy controls were evident. Compared with healthy controls, individuals with COPD had increased dyspnea and hyperinflation during peak arm exercise. Increased effort of the trapezius muscle during arm activities was also found in persons with COPD compared with healthy controls. CONCLUSIONS: There is limited evidence describing physiological responses during arm activity in individuals with COPD. Findings of this systematic review suggest that individuals with COPD have decreased cardiorespiratory responses during peak arm exercise compared with controls but increased dyspnea, hyperinflation, and arm muscle effort.


Subject(s)
Arm/physiology , Exercise Therapy/methods , Exercise Tolerance/physiology , Lung/physiopathology , Pulmonary Disease, Chronic Obstructive/physiopathology , Biomechanical Phenomena , Humans , Muscle, Skeletal/physiology , Thoracic Wall/physiology
5.
J Bras Pneumol ; 41(2): 110-23, 2015.
Article in English | MEDLINE | ID: mdl-25972965

ABSTRACT

Impairment of (inspiratory and expiratory) respiratory muscles is a common clinical finding, not only in patients with neuromuscular disease but also in patients with primary disease of the lung parenchyma or airways. Although such impairment is common, its recognition is usually delayed because its signs and symptoms are nonspecific and late. This delayed recognition, or even the lack thereof, occurs because the diagnostic tests used in the assessment of respiratory muscle strength are not widely known and available. There are various methods of assessing respiratory muscle strength during the inspiratory and expiratory phases. These methods are divided into two categories: volitional tests (which require patient understanding and cooperation); and non-volitional tests. Volitional tests, such as those that measure maximal inspiratory and expiratory pressures, are the most commonly used because they are readily available. Non-volitional tests depend on magnetic stimulation of the phrenic nerve accompanied by the measurement of inspiratory mouth pressure, inspiratory esophageal pressure, or inspiratory transdiaphragmatic pressure. Another method that has come to be widely used is ultrasound imaging of the diaphragm. We believe that pulmonologists involved in the care of patients with respiratory diseases should be familiar with the tests used in order to assess respiratory muscle function.Therefore, the aim of the present article is to describe the advantages, disadvantages, procedures, and clinical applicability of the main tests used in the assessment of respiratory muscle strength.


Subject(s)
Muscle Strength/physiology , Neuromuscular Diseases/diagnosis , Respiratory Function Tests/methods , Respiratory Muscles/physiopathology , Exhalation/physiology , Humans , Inhalation/physiology , Inspiratory Capacity , Mouth , Pressure
6.
J. bras. pneumol ; 41(2): 110-123, Mar-Apr/2015. tab, graf
Article in English | LILACS | ID: lil-745924

ABSTRACT

Impairment of (inspiratory and expiratory) respiratory muscles is a common clinical finding, not only in patients with neuromuscular disease but also in patients with primary disease of the lung parenchyma or airways. Although such impairment is common, its recognition is usually delayed because its signs and symptoms are nonspecific and late. This delayed recognition, or even the lack thereof, occurs because the diagnostic tests used in the assessment of respiratory muscle strength are not widely known and available. There are various methods of assessing respiratory muscle strength during the inspiratory and expiratory phases. These methods are divided into two categories: volitional tests (which require patient understanding and cooperation); and non-volitional tests. Volitional tests, such as those that measure maximal inspiratory and expiratory pressures, are the most commonly used because they are readily available. Non-volitional tests depend on magnetic stimulation of the phrenic nerve accompanied by the measurement of inspiratory mouth pressure, inspiratory esophageal pressure, or inspiratory transdiaphragmatic pressure. Another method that has come to be widely used is ultrasound imaging of the diaphragm. We believe that pulmonologists involved in the care of patients with respiratory diseases should be familiar with the tests used in order to assess respiratory muscle function.Therefore, the aim of the present article is to describe the advantages, disadvantages, procedures, and clinical applicability of the main tests used in the assessment of respiratory muscle strength.


O acometimento da musculatura ventilatória (inspiratória e expiratória) é um achado clínico frequente, não somente nos pacientes com doenças neuromusculares, mas também nos pacientes com doenças primárias do parênquima pulmonar ou das vias aéreas. Embora esse acometimento seja frequente, seu reconhecimento costuma ser demorado porque seus sinais e sintomas são inespecíficos e tardios. Esse reconhecimento tardio, ou mesmo a falta de reconhecimento, é acentuado porque os exames diagnósticos usados para a avaliação da musculatura respiratória não são plenamente conhecidos e disponíveis. Usando diferentes métodos, a avaliação da força muscular ventilatória é feita para a fase inspiratória e expiratória. Os métodos usados dividem-se em volitivos (que exigem compreensão e colaboração do paciente) e não volitivos. Os volitivos, como a medida da pressão inspiratória e expiratória máximas, são os mais empregados por serem facilmente disponíveis. Os não volitivos dependem da estimulação magnética do nervo frênico associada a medida da pressão inspiratória na boca, no esôfago ou transdiafragmática. Finalmente, outro método que vem se tornando frequente é a ultrassonografia diafragmática. Acreditamos que o pneumologista envolvido nos cuidados a pacientes com doenças respiratórias deve conhecer os exames usados na avaliação da musculatura ventilatória. Por isso, o objetivo do presente artigo é descrever as vantagens, desvantagens, procedimentos de mensuração e aplicabilidade clínica dos principais exames utilizados para avaliação da força muscular ventilatória.


Subject(s)
Humans , Muscle Strength/physiology , Neuromuscular Diseases/diagnosis , Respiratory Function Tests/methods , Respiratory Muscles/physiopathology , Exhalation/physiology , Inspiratory Capacity , Inhalation/physiology , Mouth , Pressure
7.
Respir Care ; 60(2): 179-82, 2015 Feb.
Article in English | MEDLINE | ID: mdl-25406341

ABSTRACT

BACKGROUND: Most patients on long-term oxygen therapy use stationary oxygen delivery systems. It is not uncommon for guidelines to instruct patients to use tubing lengths no longer than 19.68 ft (6 m) when using an oxygen concentrator and 49.21 ft (15 m) when using cylinders. However, these concepts are not based on sufficient evidence. Thus, our objective was to evaluate whether a 98.42-ft (30-m) tubing length affects oxygen flow and FIO2 delivery from 1 cylinder and 2 oxygen concentrators. METHODS: The 3 oxygen delivery systems were randomly selected, and 1, 3, and 5 L/min flows and FIO2 were measured 5 times at each flow at the proximal and distal outlets of the tubing by a gas-flow analyzer. Paired Student t test was used to analyze the difference between flows and FIO2 at proximal and distal outlets of tubing length. RESULTS: A total of 45 flows were measured between proximal and distal outlets of the 98.42-ft (30-m) tubing. Flows were similar for 1 and 3 L/min, but distal flow was higher than proximal flow at 5 L/min (5.57×5.14 L/min, P<.001). FIO2 was lower at distal than proximal outlet tubing at flows 1, 3, and 5 L/min, but the mean difference between measurements was less than 1%. CONCLUSIONS: Tubing length of 98.42 ft (30 m) may be used by patients for home delivery oxygen with flows up to 5 L/min, as there were no important changes in flows or FIO2.


Subject(s)
Oxygen Inhalation Therapy/instrumentation , Oxygen/administration & dosage , Self Care/instrumentation , Equipment Design , Guidelines as Topic , Humans , Random Allocation , Reproducibility of Results , Time Factors
8.
PLoS One ; 8(11): e79727, 2013.
Article in English | MEDLINE | ID: mdl-24278164

ABSTRACT

OBJECTIVES: To measure the oxygen and ventilatory output across all COPD stages performing 18 common ADL and identify the activities that present the highest metabolic and ventilatory output as well as to compare the energy expenditure within each disease severity. MATERIALS AND METHODS: Metabolic (VO2 and VCO2), ventilatory (f and VE), cardiovascular (HR) and dyspnea (Borg score) variables were assessed in one hundred COPD patients during the completion of eighteen ADL grouped into four activities domains: rest, personal care, labor activities and efforts. RESULTS: The activities with the highest proportional metabolic and ventilatory output (VO2/VO2max and VE/MVV) were walking with 2.5 Kg in each hand and walking with 5.0 Kg in one hand. Very severe patients presented the highest metabolic, ventilatory output and dyspnea than mild patients (p<0.05). CONCLUSIONS: COPD patients present an increased proportion of energy expenditure while performing activities of daily living. The activities that developed the highest metabolic and ventilatory output are the ones associated to upper and lower limbs movements combined. Very severe patients present the highest proportional estimated metabolic and ventilatory output and dyspnea. Activities of daily living are mainly limited by COPD's reduced ventilatory reserve.


Subject(s)
Oxygen Consumption/physiology , Pulmonary Disease, Chronic Obstructive/physiopathology , Activities of Daily Living , Aged , Dyspnea/physiopathology , Female , Humans , Male , Maximal Voluntary Ventilation , Middle Aged , Pulmonary Ventilation , Spirometry
9.
Pulmäo RJ ; 22(2): 65-69, 2013. tab
Article in Portuguese | LILACS | ID: lil-704341

ABSTRACT

A DPOC é uma doença sistêmica que está associada com alteração da função pulmonar e disfunção dos músculos esqueléticos, que contribuem para a redução da tolerância ao exercício. Vários fatores contribuem para a redução da tolerância ao exercício, como inatividade física, uso de corticosteroides, tabagismo, desnutrição, deficiência de anabolizantes, inflamação sistêmica, estresse oxidativo e hipóxia. O cuidado ideal aos pacientes com DPOC geralmente requer a combinação de tratamentos farmacológicos e não farmacológicos. A reabilitação pulmonar é um tratamento abrangente e inclui treinamento físico,educação do paciente, oxigenoterapia, apoio psicossocial e intervenção nutricional. A reabilitação pulmonar tem demonstrado eficácia para melhorar a dispneia, a capacidade de exercício e a qualidade de vida. Devido ao elevado número de pacientes com DPOC e ao baixo número de centros de reabilitação pulmonar, um programa de reabilitação domiciliar temsido estudado e desenvolvido para aumentar o número de pacientes a serem tratados


Having recently been classified as a systemic disease, COPD is associated with impaired pulmonary function and skeletal muscle dysfunction, the combination of which results in low exercise tolerance. Many other factors also contribute to the reduction in exercise tolerance in COPD, including physical inactivity, corticosteroid use, smoking, malnutrition, deficienciesin anabolic hormones, systemic inflammation, hypoxia, and oxidative stress. The optimal care of patients with COPD typically requires a combination of pharmacological and non-pharmacological treatment. Pulmonary rehabilitation is a comprehensive treatment that includes exercise training, patient education, psychosocial supportand nutritional intervention. Pulmo-nary rehabilitation has proven effective in reducing dyspnea, as well as in improving exercise capacity and health-related quality of life. Due to the high number of COPD patients and to the low number of pulmonary rehabilitation centers, a home based rehabilitation program has been developed in order to increase the number of patients receiving such treatment


Subject(s)
Humans , Pulmonary Disease, Chronic Obstructive/rehabilitation , Pulmonary Disease, Chronic Obstructive/therapy , Exercise Therapy , Quality of Life
10.
Chest ; 138(1): 39-46, 2010 Jul.
Article in English | MEDLINE | ID: mdl-20202941

ABSTRACT

BACKGROUND: Increased ventilation during upper limb exercises (ULE) in patients with COPD is associated with dynamic hyperinflation (DH) and a decrease in inspiratory capacity (IC). The best level of ULE load training is still unknown. Our objective was to evaluate the dynamic hyperinflation development during ULE using three constant workloads. METHODS: This was a prospective, randomized protocol involving 24 patients with severe COPD (FEV(1) < 50%) performing an endurance symptom-limited arm exercise of up to 20 min in an arm cycloergometer with different workloads (50%, 65%, and 80% of the maximal load). Ventilation, metabolic, and lung function variables (static IC pre-exercise and postexercise) were measured. RESULTS: DH was observed during exercises with 65% (-0.23 L) and 80% (-0.29 L) workloads (P < .0001). Total time of exercise with 80% workload (7.6 min) was shorter than with 50% (12.5 min) (P < .0005) and with 65% (10.1 min; not significant). Oxygen consumption percent predicted (VO(2)) (P < .01) was lower with 50% workload than with 80%. Eighty percent workload showed lower work efficiency (VO(2) [mL/kg]/exercise time) than the other two workloads (P < .0001). CONCLUSION: Different workloads during upper limb exercises showed a direct influence over dynamic hyperinflation and the endurance exercise duration.


Subject(s)
Exercise Therapy/methods , Exercise Tolerance/physiology , Pulmonary Disease, Chronic Obstructive/rehabilitation , Total Lung Capacity/physiology , Upper Extremity/physiology , Female , Follow-Up Studies , Humans , Inspiratory Capacity/physiology , Male , Middle Aged , Oxygen Consumption/physiology , Prognosis , Prospective Studies , Pulmonary Disease, Chronic Obstructive/physiopathology
SELECTION OF CITATIONS
SEARCH DETAIL
...